LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 5 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 2. - Dataset (ID:20313)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 51.90 | 19.50 | 421 | 4974 | 0.0849 | 0.3263 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 53.90 | 19.50 | 414 | 5154 | 0.0806 | 0.3168 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 55.90 | 19.50 | 408 | 5348 | 0.0769 | 0.3093 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 57.80 | 19.50 | 405 | 5483 | 0.0746 | 0.2992 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 59.80 | 19.50 | 401 | 5578 | 0.0726 | 0.2964 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 62.80 | 19.50 | 398 | 5586 | 0.0718 | 0.2648 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 64.70 | 19.50 | 391 | 5643 | 0.0698 | 0.2600 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 66.70 | 19.50 | 395 | 5728 | 0.0693 | 0.2373 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 68.70 | 19.50 | 388 | 5743 | 0.0678 | 0.2469 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 70.70 | 19.50 | 373 | 5784 | 0.0648 | 0.2210 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 72.60 | 19.50 | 367 | 5854 | 0.0628 | 0.2033 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 74.60 | 19.50 | 360 | 5927 | 0.0609 | 0.1888 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.60 | 19.50 | 352 | 5898 | 0.0597 | 0.1943 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.50 | 19.50 | 329 | 5949 | 0.0554 | 0.1834 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.50 | 19.50 | 307 | 6018 | 0.0510 | 0.1721 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.50 | 19.50 | 304 | 6031 | 0.0504 | 0.1574 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.40 | 19.50 | 288 | 6038 | 0.0478 | 0.1459 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 86.40 | 19.50 | 282 | 6081 | 0.0463 | 0.1521 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 88.40 | 19.50 | 266 | 6064 | 0.0439 | 0.1364 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 90.40 | 19.50 | 247 | 6097 | 0.0405 | 0.1226 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 92.30 | 19.50 | 229 | 6153 | 0.0373 | 0.1187 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 94.30 | 19.50 | 223 | 6154 | 0.0365 | 0.1113 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 2.70 | 19.50 | 247 | 163 | 1.4658 | 0.5955 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 4.60 | 19.50 | 335 | 295 | 1.1253 | 0.4615 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 6.60 | 19.50 | 404 | 390 | 1.0341 | 0.4523 |